K279-1152 Screening compound: 2-({3-[2-(CYCLOHEXYLAMINO)-2-OXOETHYL]-2-OXO-2,3-DIHYDROIMIDAZO[1,2-C]QUINAZOLIN-5-YL}SULFANYL)-N~1~-(3,4-DIMETHOXYPHENETHYL)ACETAMIDE

K279-1152 Screening compound: 2-({3-[2-(CYCLOHEXYLAMINO)-2-OXOETHYL]-2-OXO-2,3-DIHYDROIMIDAZO[1,2-C]QUINAZOLIN-5-YL}SULFANYL)-N~1~-(3,4-DIMETHOXYPHENETHYL)ACETAMIDE
K279-1152 Screening compound: 2-({3-[2-(CYCLOHEXYLAMINO)-2-OXOETHYL]-2-OXO-2,3-DIHYDROIMIDAZO[1,2-C]QUINAZOLIN-5-YL}SULFANYL)-N~1~-(3,4-DIMETHOXYPHENETHYL)ACETAMIDE alternative view

Chemical Structure Depiction of ChemDiv screening compound K279-1152
2-({3-[2-(CYCLOHEXYLAMINO)-2-OXOETHYL]-2-OXO-2,3-DIHYDROIMIDAZO[1,2-C]QUINAZOLIN-5-YL}SULFANYL)-N~1~-(3,4-DIMETHOXYPHENETHYL)ACETAMIDE

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

K279-1152

Molecular Formula

C30H35N5O5S (C30 H35 N5 O5 S)

Compound Name

2-({3-[2-(CYCLOHEXYLAMINO)-2-OXOETHYL]-2-OXO-2,3-DIHYDROIMIDAZO[1,2-C]QUINAZOLIN-5-YL}SULFANYL)-N~1~-(3,4-DIMETHOXYPHENETHYL)ACETAMIDE

IUPAC name

n/a

SMILES

COc(ccc(CCNC(CSC(N1C2CC(NC3CCCCC3)=O)=Nc(cccc3)c3C1=NC2=O)=O)c1)c1OC

InChI

InChI=1S/C30H35N5O5S/c1-39-24-13-12-19(16-25(24)40-2)14-15-31-27(37)18-41-30-33-22-11-7-6-10-21(22)28-34-29(38)23(35(28)30)17-26(36)32-20-8-4-3-5-9-20/h6-7,10-13,16,20,23H,3-5,8-9,14-15,17-18H2,1-2H3,(H,31,37)(H,32,36)/t23-/m0/s1

InChI Key

AVCJVDQFYDWHST-QHCPKHFHSA-N

MDL Number (MFCD)

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

577.7

Hydrogen Bond Acceptors Count

11.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

13.00

Number of Nitrogen and Oxygen Atoms

10

Partition Coefficient, logP

2.212

Distribution Coefficient, logD

2.211

Water Solubility, LogSw

-2.97

Polar Surface Area

98.922

Acid Dissociation Constant (pKa)

11.05

Base Dissociation Constant (pKb)

4.86

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

43.30

K279-1152 in Drug Discovery

Included in Screening Libraries

3CLpro Library (4801 compounds)

CORONAVIRUS Library (20774 compounds)

Eccentric PPI Library (11937 compounds)

Protein-Protein Interaction Library (218420 compounds)

Regenerative Medicine Focused Library (23016 compounds)

Histone Deacetylases (HDAC) Targeted Library (9760 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Antiviral
  • Infections
  • Immune system
  • Musculoskeletal
  • Digestive system
  • Hemic and lymphatic
  • Cardiovascular
  • Skin
  • wounds
  • Cancer
  • Nervous system
  • Hemic and lymphatic
  • Endocrine
  • Immune system
Mechanism of action:
  • PPI modulators
  • PPI modulators
  • Epigenetic
Structure:
  • Cyclic compounds

References: we are preparing a list of scientific research reports with K279-1152 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound K279-1152?
Check Price and Availability of K279-1152, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of K279-1152 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for K279-1152
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for K279-1152
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of K279-1152 available by request